BioNote, Inc. (KRX: 377740)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,675.00
+30.00 (0.65%)
Nov 19, 2024, 9:07 AM KST

BioNote Revenue

BioNote had revenue of 26.28B KRW in the quarter ending June 30, 2024, with 3.40% growth. This brings the company's revenue in the last twelve months to 95.08B, down -27.96% year-over-year. In the year 2023, BioNote had annual revenue of 90.08B, down -81.22%.

Revenue (ttm)
95.08B
Revenue Growth
-27.96%
P/S Ratio
4.99
Revenue / Employee
319.06M
Employees
n/a
Market Cap
474.05B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202390.08B-389.58B-81.22%
Dec 31, 2022479.66B-142.70B-22.93%
Dec 31, 2021622.36B-9.15B-1.45%
Dec 31, 2020631.50B591.46B1,476.89%
Dec 31, 201940.05B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition